Holger Rumpold

11PUBLICATIONS
30CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 30, 2025
Rapid Hematological and Molecular Response to Pegylated Interferon in WHO-Defined Pre-Fibrotic Myelofibrosis.

Sigrid Machherndl-Spandl, Marcel Kiehberger, Veronika Sygulla

|Feb 04, 2025
Baseline Liquid Biopsy in Relation to Tissue-Based Parameters in Metastatic Colorectal Cancer: Results From the Randomized FIRE-4 (AIO-KRK-0114) Study.

Sebastian Stintzing, Susanne Klein-Scory, Ludwig Fischer von Weikersthal

|Dec 17, 2024
Circulating Tumor DNA (ctDNA) Dynamics Predict Early Response to Treatment in Metastasized Gastroesophageal Cancer (mGEC) After 2 Weeks of Systemic Treatment.

Stefan Tatalovic, Bernhard Doleschal, Alexander Kupferthaler

|Oct 16, 2024
Improved Outcomes in Myelofibrosis after Allogeneic Stem-Cell Transplantation in the Era of Ruxolitinib Pretreatment and Intensified Conditioning Regimen-Single-Center Analysis.

Sigrid Machherndl-Spandl, Sarah Hannouf, Alexander Nikoloudis

|Oct 03, 2023
Response prediction by mutation- or methylation-specific detection of ctDNA dynamics in pretreated metastatic colorectal cancer.

Bernhard Doleschal, Patrick Kirchweger, Simon Schwendinger

|Jan 03, 2022
Improvement in colorectal cancer outcomes over time is limited to patients with left-sided disease.

Holger Rumpold, M Hackl, A Petzer

Pageof 2

Frequent Collaborators

3 joint publications

Gerald Webersinke

2 joint publications

Alexander Kupferthaler

2 joint publications

Otto Zach

2 joint publications

Irene Strassl